Clinical Trial Update: Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a multi-classifier system to stratify stage III papillary renal cell carcinoma in the adjuvant therapy setting; not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Renal Cell Carcinoma

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Papillary Renal Cell Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING